Enteral Medical Nutrition Market Forecast to 2028
The global enteral medical nutrition market is expected to reach US$11,726. 37 million by 2028 from $7,803. 45 million in 2021; it is expected to grow at a CAGR of 6.0% from 2022 to 2028.
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Indication, Nutrition Type, Form, Product, Distribution Chain and age range [Child and Adults ]- https://www.reportlinker.com/p06321036/?utm_source=GNW
Enteral nutrition (EN) is provided to patients whose energy and nutrient needs cannot be met by regular food intake. The advantages of enteral intake over parenteral nutrition are well known.
For most pediatric patients who rely on enteral nutrition, a standard, age-appropriate, fiber-enriched polymer formula is an appropriate choice.
Crohn’s disease, gastrointestinal diseases due to trauma, intestinal obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are some gastrointestinal diseases. According to the Heathline article, in 2021 around 40% of people worldwide were affected by a functional gastrointestinal disorder.
According to Medscape, in developed countries, the most common cause of small bowel obstruction (SBO) is intra-abdominal adhesions, which account for about 65-75% of cases, followed by hernias. In contrast, in developing countries, BOS is mainly caused by hernias (30-40%), adhesions (about 30%) and tuberculosis (about 10%).
According to the article published by the World Journal of Emergency Surgery, bowel obstruction is a significant cause of morbidity and mortality, responsible for nearly 30,000 deaths and more than US$3 billion annually in direct medical costs. Bowel obstruction is responsible for approximately 15% of hospital admissions for acute abdominal pain in the United States, and approximately 20% of cases require acute surgical care.
Crohn’s disease is a complex and long-lasting (chronic) disease that mainly affects the digestive system. It is the most common disease in North America and Western Europe and its prevalence is 100 to 300 per 100,000 in these regions.
According to Medline Plus, more than half a million people in North America and Western Europe currently have Crohn’s disease. Patients affected by gastrointestinal disease are at increased risk of nutritional deterioration due to fasting for diagnostic tests, therapeutic food restriction, and loss of appetite due to anorexia or altered nutritional needs developed by the disease. herself.
Enteral medical nutrition is preferred for patients with gastrointestinal diseases as these patients cannot consume food orally. Hence, the rising prevalence of gastrointestinal diseases across the globe is driving the growth of the enteral medical nutrition market.
Based on indications, enteral medical nutrition market is segmented on the basis of respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure and others. The respiratory disorders segment market is further segmented into chronic obstructive pulmonary diseases, respiratory failure, cystic fibrosis and others.
In 2021, the respiratory disorders segment held the largest market share. The rising prevalence of respiratory diseases is driving the market growth for the segment.
According to the National Hospital Ambulatory Medical Care Survey: 2018, there were 873,000 emergency department visits due to COPD in the United States. The Cancer segment market is sub-segmented into Cancer Cachexia, Cachexia with COPD and Others.
The cancer segment is expected to register the highest CAGR between 2022 and 2028. The enteral medical nutrition market for gastrointestinal disorders segment is further segmented into bowel obstruction, Crohn’s disease, short bowel syndrome and others.
On the basis of nutrition type, enteral medical nutrition market is divided into supplement and single source. The supplements segment held a larger share of the market in 2021.
However, the sole-source segment is expected to register a higher CAGR during the forecast period.
On the basis of form, the enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period.
On the basis of product, the enteral medical nutrition market is segmented into standard protein diet, high protein diet, oral juice-based nutrition and others. The standard protein diet segment held the largest market share in 2021.
However, the fruit juice-based oral nutritional supplement segment is expected to register the highest CAGR during the forecast period.
Based on the distribution channel, the enteral medical nutrition market is segmented into hospital pharmacies, retail stores and other pharmacies. The hospital pharmacy segment held the largest market share in 2021.
However, the retail store segment is expected to register the highest CAGR during the forecast period.
Based on age, enteral medical nutrition market is divided into child (up to 18 years old) and adult (18+ years old). The adult segment (18+) held a larger share of the market in 2021.
However, the children segment (up to 18 years old) is expected to register a higher CAGR during the forecast period.
The World Health Organization (WHO), American Society of Parenteral and Enteral Nutrition, American Society of Clinical Oncology, and Centers for Disease Control and Prevention are some of the primary and secondary sources it is made to reference while preparing the Enteral Medical Nutrition market report.
Read the full report: https://www.reportlinker.com/p06321036/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001